Form 4 for CVNA Carvana
Accepted 2025-12-12 00:00:00 ET · period of report 2025-12-12 · accession 0001700538-25-000015 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-12-12 | 2025-12-12 | CVNA | GILL DANIEL J. | Chief Product Off | S - Sale+OE | $475.24 | -40.0K | 193.2K | -17% | -$19.01M |
| DM | 2025-12-12 | 2025-12-12 | CVNA | GILL DANIEL J. | Chief Product Off | M - OptEx | $15.08 | +40.0K | 224.8K | +22% | +$603.1K |
| DM | 2025-12-12 | 2025-12-12 | CVNA | GILL DANIEL J. | Chief Product Off | M - OptEx | $0.00 | -40.0K | 55.1K | -42% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-12-12 | S | D | 2,120 | $476.00 | 191,106 | D | — | — | (F1) The reported option exercises and sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2024 (the "10b5-1 Plan"). (F4) This transaction was executed in multiple trades at prices ranging from $476.00 to $476.01 inclusive. (F2) The price reported above reflects the volume weighted average sale price. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price. |
| 2 | Common | Class A Common Stock | 2025-12-12 | S | D | 37,880 | $475.20 | 193,226 | D | — | — | (F1) The reported option exercises and sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2024 (the "10b5-1 Plan"). (F3) This transaction was executed in multiple trades at prices ranging from $475.00 to $475.91 inclusive. (F2) The price reported above reflects the volume weighted average sale price. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price. |
| 3 | Common | Class A Common Stock | 2025-12-12 | M | A | 6,268 | $42.03 | 231,106 | D | — | — | (F1) The reported option exercises and sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2024 (the "10b5-1 Plan"). |
| 4 | Common | Class A Common Stock | 2025-12-12 | M | A | 33,732 | $10.07 | 224,838 | D | — | — | (F1) The reported option exercises and sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2024 (the "10b5-1 Plan"). |
| 5 | Derivative | Stock Options (Right to Buy) | 2025-12-12 | M | D | 33,732 | $0.00 | 167,170 | D | $10.07 · 2024-04-01 to 2033-02-22 | 33,732 Class A Common Stock | (F5) The non-qualified stock options representing the right to purchase for the exercise price Class A Common Stock of the Issuer vested 25% on April 1, 2024 and monthly thereafter for the following three years, subject to the Reporting Person's continued service with the Issuer. |
| 6 | Derivative | Stock Options (Right to Buy) | 2025-12-12 | M | D | 6,268 | $0.00 | 55,133 | D | $42.03 · 2025-04-01 to 2034-01-24 | 6,268 Class A Common Stock | (F6) The non-qualified stock options representing the right to purchase for the exercise price Class A Common Stock of the Issuer vest 25% on April 1, 2025 and monthly thereafter for the following three years, subject to the Reporting Person's continued service with the Issuer. |